Bliq wins Finland approval for supervised autonomous-road tests
Bliq.ai can begin public-road testing in Finland, but the approval still requires an onboard safety driver and does not amount to a commercial driverless launch.
Finland has cleared Bliq.ai to begin autonomous-driving operations on public roads, giving the startup a valuable test environment. But the approval is narrower than a full driverless deployment.
What happened
Bliq received permission to test its autonomous-driving system around Helsinki. Initial operations will continue to use an onboard safety driver.
The company’s approach is based on upgrading existing software-defined vehicles with additional sensors and computing hardware rather than building a purpose-designed robotaxi from the ground up. Its current system combines Level 2 driving automation with remote human supervision.
That means Bliq’s vehicles can assist with driving tasks, but responsibility has not shifted fully away from a human operator. The approval should therefore be understood as a supervised testing milestone, not authorisation for an unsupervised commercial robotaxi service.
Why it matters
Finland offers difficult conditions for autonomous systems, including snow, limited daylight and rapidly changing road surfaces. Successful testing there could provide stronger evidence of resilience than operating only in warm, highly mapped environments.
Bliq’s retrofit strategy may also reduce capital requirements. Using existing vehicle platforms could shorten deployment timelines and avoid the cost of manufacturing a dedicated autonomous vehicle.
The bigger picture
Autonomous-driving companies are pursuing different paths to market. Some build fully integrated robotaxis and seek driverless operation immediately. Others add capability gradually through supervised systems, retrofits and remote support.
Bliq sits closer to the second model. That may be commercially pragmatic, but it creates a communication risk: regulatory approval for testing can sound more advanced than the underlying autonomy level. The company’s next meaningful milestones will be evidence of safety, reduced human intervention and a credible path from supervised trials to revenue-generating operations.